Renin Genetic Polymorphism in Heart Failure Patients

1. NGUYEN G, MULLER DN. The biology of the (pro) renin receptor. J Am Soc Nephrol. 2010; 21(1):18-23.10.1681/ASN.200903030019917780Search in Google Scholar

2. SCHALEKAMP MA, DERKX FH, DEINUM J, DANSER AJ. Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors. J Hypertens. 2008; 26(5):928-937. Review.10.1097/HJH.0b013e3282f6a67118398335Search in Google Scholar

3. VOLPE M, BATTISTONI A, CHIN D, RUBATTU S, TOCCI G. Renin as a biomarker of cardiovascular disease in clinical practice. Nutr Metab Cardiovasc Dis. 2012; 22 (4):312-317.10.1016/j.numecd.2011.12.00622402063Search in Google Scholar

4. DICKSTEIN K, COHEN-SOLAL A, FILIPPATOS G, MCMURRAY JJ, PONIKOWSKI P, POOLE-WILSON PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J. 2008; 29:2388-2442.10.1093/eurheartj/ehn30918799522Search in Google Scholar

5. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Technical Report Series 2000; 894: i-xii,1-253.Search in Google Scholar

6. RUPERT JL, KIDD KK, NORMAN LE, MONSALVE MV, HOCHACHKA PW, DEVINE DV. Genetic polymorphisms in the renin-angiotensin system in high altitude and low altitude native American populations. Ann Hum Genet 2003; 67: 17-25.10.1046/j.1469-1809.2003.00004.x12556231Search in Google Scholar

7. PROCOPCIUC LM, CARACOSTEA G, ZAHARIE G, PUSCAS M, IORDACHE G, POPA M, et al. Maternal/newborn genotype contribution of the renin-angiotensin system [Met235Thr, Thr174Met, I/D-ACE, A2350G-ACE, A1166C-AT2R1, C3123A- AT2R2, 83A/G- REN] to the risk of pre-eclampsia: a Romanian study. J Renin Angiotensin Aldosterone Syst. 2011; 12(4):539-548.10.1177/147032031139960321436209Search in Google Scholar

8. McMURRAY JJ, ADAMOPOULOS S, ANKER SD, AURICCHIO A, BÖHM M, DICKSTEIN K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association [HFA] of the ESC. EHJ 2012:33; 1787-1847.Search in Google Scholar

9. BRUNNER HR, LARAGH JH, BAER L, NEWTON MA, GOODWIN FT, KRAKOFF LR, et al. Essential hypertension: renin and aldosteron, heart attack and stroke. N Engl J Med 1972; 286: 441-449.10.1056/NEJM1972030228609014257928Search in Google Scholar

10. ALDERMAN MH, MADHAVAN S, OOI WL, COHEN H, SEALEY JE, LARAGH JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991; 324:1098-1104.10.1056/NEJM1991041832416051759997Search in Google Scholar

11. PARIKH NI, GONA P, LARSON MG, WANG TJ, NEWTON-CHEH C, LEVY D, et al. Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study. Eur Heart J 2007; 28:2644-2652.10.1093/eurheartj/ehm39917895253Search in Google Scholar

12. POP DANA. Sistemul Renină-Angiotensină-Aldosteron în patogeneza bolilor cardiovasculare. Editura Clusium, Cluj-Napoca, 2007.Search in Google Scholar

13. ALDI S, MARINO A, TOMITA K, CORTI F, ANAND R, OLSON KE, MARCUS AJ, LEVI R. E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role. FASEB J. 2014 Oct 15. pii: fj.14-261867.10.1096/fj.14-261867428553725318477Search in Google Scholar

14. SIM JJ, SHI J, AL-MOOMEN R, BEHAYAA H, KALANTAR-ZADEH K, JACOBSEN SJ. Plasma Renin activity and its association with ischemic heart disease, congestive heart failure, and cerebrovascular disease in a large hypertensive cohort. J Clin Hypertens (Greenwich). 2014; 16(11):805-813.10.1111/jch.12419Search in Google Scholar

15. SEVER PS, CHANG CL, PRESCOTT MF, GUPTA A, POULTER NR, WHITEHOUSE A, SCANLON M. Is plasma rennin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Eur Heart J. 2012; 33(23):2970-2979.10.1093/eurheartj/ehs241Search in Google Scholar

16. BENEDICT CR, SHELTON B, JOHNSTONE DE, FRANCIS G, GREENBERG B, KONSTAM M, et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 1996; 94:690-697.10.1161/01.CIR.94.4.690Search in Google Scholar

17. VALDEZ-VELAZQUEZ LL, MENDOZA-CARRERA F, PEREZ-PARRA SA, RODARTE-HURTADO K, SANDOVALRAMIREZ L, MONTOYA-FUENTES H, et al. Renin gene haplotype diversity and linkage disequilibrium in two Mexican and one German population samples. J Renin Angiotensin Aldosteron Syst. 2011; 12(3):231-237.10.1177/1470320310388440Search in Google Scholar

18. SUN B, WILLIAMS JS, POJOGA L, CHAMARTHI B, LASKY-SU J, RABY BA, et al. Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses. J ReninAngiotensin Aldosterone Syst. 2011; 12 (4):564-571.10.1177/1470320311405873Search in Google Scholar

19. SCHLING P, LÖFFLER G. Effects of angiotensin II on adipose conversion and expression of genes of the renin-angiotensin system in human preadipocytes. Horm Metab Res. 2001; 33(4):189-95.10.1055/s-2001-14951Search in Google Scholar

20. BARTON M, CARMONA R, ORTMANN J, KRIEGER JE, TRAUPE T. Obesity-associated activation of angiotensin and endothelin in the cardiovascular system. Int J Biochem Cell Biol. 2003; 35(6):826-837.10.1016/S1357-2725(02)00307-2Search in Google Scholar

21. GEORGE BAKRIS. Are There Effects of Renin-Angiotensin System Antagonists Beyond Blood Pressure Control? American Journal of Cardiology. 2010; (105):21A-29A.10.1016/j.amjcard.2009.10.010Search in Google Scholar

22. NISHIYAMA K, TSUTAMOTO T, KAWAHARA C, YAMAJI M, SAKAI H, YAMAMOTO T, et al. Relationship between biological variation in B-type natriuretic peptide and plasma rennin concentration in stable outpatients with dilated cardiomyopathy. Circ J. 2011; 75(8):1897-1904.10.1253/circj.CJ-10-1083Search in Google Scholar

23. VREDEVOR DL, WOO MA, DOERING LV, BRECHT ML, HAMILTON MA, FONAROW GC. Skin test anergy in advanced chronic heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1998; 82: 323-328.10.1016/S0002-9149(98)00334-8Search in Google Scholar

24. RAUCHHAUS M, KOLOCZEK V, HANS-DIETER V, KEMP M, NIEBAUER J, FRANCIS DP, et al. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol. 2000; 76: 125-133.10.1016/S0167-5273(00)00224-2Search in Google Scholar

25. RAUCHHAUS M, COATS AJS, ANKER SD. The endotoxin-lipoprotein hypothesis. Lancet. 2000; 356: 930-933.10.1016/S0140-6736(00)02690-8Search in Google Scholar

26. RAUCHHAUS M, CLARK AL, DOEHNER W, DAVOS C, BOLGER A, SHARMA R, et al. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol.2003; 42:1933-1940.10.1016/j.jacc.2003.07.01614662255Search in Google Scholar

27. WANG TJ, GONA P, LARSON MG, TOFLER GH, LEVY D, NEWTON-CHEH C, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355:2631-2639. 10.1056/NEJMoa05537317182988Search in Google Scholar